QURE
QURE
NASDAQ · Biotechnology

Uniqure Nv

$16.09
+0.83 (+5.44%)
As of Mar 22, 10:07 PM ET ·
Financial Highlights (FY 2026)
Revenue
33.92M
Net Income
-299,653,025
Gross Margin
32.4%
Profit Margin
-883.4%
Rev Growth
-62.7%
D/E Ratio
2.39
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 32.4% 32.4% 45.0% 45.0%
Operating Margin -679.6% -611.6% 12.4% 10.9%
Profit Margin -883.4% -839.2% 12.0% 12.1%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 33.92M 91.01M 366.27M 316.03M
Gross Profit 11.00M 29.51M 164.91M 142.29M
Operating Income -230,510,403 -556,639,019 45.48M 34.44M
Net Income -299,653,025 -723,605,372 43.81M 38.10M
Gross Margin 32.4% 32.4% 45.0% 45.0%
Operating Margin -679.6% -611.6% 12.4% 10.9%
Profit Margin -883.4% -839.2% 12.0% 12.1%
Rev Growth -62.7% -62.7% -4.9% -4.4%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 510.44M 510.44M 204.81M 207.31M
Total Equity 213.72M 213.72M 806.10M 940.40M
D/E Ratio 2.39 2.39 0.25 0.22
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -214,714,214 -547,299,445 53.48M 50.33M
Free Cash Flow 19.66M 18.73M